Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Am J Med Sci. 2010 Dec;340(6):448–451. doi: 10.1097/MAJ.0b013e3181ee6a62

Table 3.

CCR5 genotype/PCR+ in ReAa and UOa samples

ReAa
Gender
wt/wt
wt/Δ32
PCR+
PCR+ wt/Δ32
F 53 45 (85%) 8 (15%) 32 (60%) 8 (100%)b
M 57 51 (90%) 6 (11%) 37 (65%) 2 (33%)
110 96 (87%) 14 (13%) 69 (63%) 10 (14% of positives/9% of total)
UOa
F 53 41 (77%) 12 (23%) 9 (17%) 1 (8%)c
M 30 23 (77%) 7 (23%) 7 (23%) 0 (0%)
83 64 (77%) 19 (23%) 16 (19%) 1 (6% of positives/1% of total)
OAa
F 3 3 (75%) 0 (0%) 0 (0%) 0 (0%)
M 1 0 (0%) 1 (25%) 0 (0%) 0 (0%)
4 3 (75%) 1 (25%) 0 (0%) 0 (0% of total)
a

Abbreviations as given in the legend to Table 1

b

p=0.5642 PCR+wt/Δ32 vs PCR+wt/wt

c

p=0.1026 PCR+wt/Δ32 vs PCR+wt/wt